What Hurts Dental Practice Business Valuations?

Five things consistently hurt dental practice valuations in 2026: staffing instability, heavy insurance network dependency, declining hygiene recare rates, owner-dentist clinical dependency, and new DSO buyer discipline that's rationalizing the roll-up market after a decade of aggressive expansion. EBITDA margins are down roughly 5 percentage points since 2022 across the industry, 91% of practices struggle to recruit hygienists, and 35% of dentists plan to drop out of insurance networks in 2026. DSO acquirers — Heartland Dental, Aspen Dental, Pacific Dental Services, Smile Brands, and MB2 Dental — are paying more selectively.

Quick Numbers: 5% EBITDA margin compression since 2022 | 91% of practices can't recruit hygienists | 35% plan to drop insurance networks in 2026 | DSO multiples plateauing at 4.5x-7.0x for sub-scale practices

Why Staffing Problems Hit Multiples Harder Than Revenue Declines

The single biggest valuation headwind in 2026 is hygienist availability. When a practice can't staff its hygiene schedule, two things happen: revenue drops because visits get deferred, and EBITDA drops more than proportionally because fixed costs (rent, front desk, associate dentist time) stay constant. Buyers model forward on hygiene capacity, not current hygiene production — a practice with two empty hygiene chairs and a six-month hire timeline gets underwritten as if those chairs stay empty, and the multiple reflects that. For the fuller picture on where dental practices are trading, see my dental practice valuation hub.

What Actually Still Commands Premium Pricing

Practices that hold 2025-era multiples in 2026 share four characteristics. First, a fee-for-service revenue component of 25%+ — buyers pay for pricing freedom. Second, a production-independent associate bench, meaning 40%+ of clinical production comes from associates, not the owner-dentist. Third, recare rates above 75% with clean patient data verifying it. Fourth, three years of GAAP-clean financials that survive a Quality of Earnings review without surprises. Owners checking most of those boxes still have DSO and strategic buyer attention. Owners who don't should expect compressed multiples and a longer sale timeline. For context on SDE multiples specifically for dental practices, see the related piece on dental SDE multiples.

"The dental practice owners most surprised by 2026 pricing are the ones who watched DSO multiples in 2021 and 2022 and assumed those would carry. They won't. The DSO platforms I'm in contact with are paying for EBITDA durability, associate-driven production, and insurance independence — not just for revenue or chair count. I'd tell any owner planning an exit in the next eighteen months: fix your hygiene staffing, build an associate's book, and get your books clean. That's where the multiple is." — John M. Salony

Find Out What Your Dental Practice Business Is Worth

Start with the free valuation calculator — it benchmarks your collections, payer mix, and associate production against 2026 DSO and strategic-buyer comps in about ten minutes.

Schedule a Confidential Consultation

Frequently Asked Questions

Why Staffing Problems Hit Multiples Harder Than Revenue Declines
The single biggest valuation headwind in 2026 is hygienist availability. When a practice can't staff its hygiene schedule, two things happen: revenue drops because visits get deferred, and EBITDA drops more than proportionally because fixed costs — rent, front desk, associate dentist time — stay constant. Buyers model forward on hygiene capacity, not current hygiene production. A practice with two empty hygiene chairs and a six-month hire timeline gets underwritten as if those chairs stay empty, and the multiple reflects that. Owners need to solve the staffing problem before going to market, not hope a buyer will solve it post-close. The same buyer discipline applies to associate recruiting — unfilled associate capacity is priced as risk, not as upside.
What Actually Still Commands Premium Pricing
Practices holding 2025-era multiples in 2026 share four characteristics. A fee-for-service revenue component of 25%+ — buyers pay for pricing freedom and insurance-independence. A production-independent associate bench, meaning 40%+ of clinical production comes from associates rather than the owner-dentist. Recare rates above 75% with clean patient data verifying it, because recare is the single best predictor of durable hygiene revenue. And three years of GAAP-clean financials that survive a Quality of Earnings review without surprises. Owners checking most of those boxes still have DSO and strategic buyer attention. Owners who don't should expect compressed multiples and a longer sale timeline. The fixes typically take twelve to eighteen months of operational work before listing.